Coleen Glessner

EVP, Quality & Ethics, and CPL, Emergent BioSolutions Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.0M

Companies

Latest trade

Oct 7, 2025

Companies

Emergent BioSolutions Inc.EVP, Quality & Ethics, and CPL −$0.3M

Trades

EBS Sold 30,608 shares at $10.00 · planned $0.3M Oct 7

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.